|

Fluorodopa F 18 Clinical Trials

3 actively recruiting trials across 2 locations

No change since May 2026

Also known as: (18F)FDOPA, 18F-DOPA, 18F-FDOPA, 3-(2-Fluoro-(sup 18)F-4,5-dihydroxyphenyl)-L-alanine, 6-(18F)Fluoro-L-DOPA +8 more

Pipeline

Early 1: 1Phase 1: 1Phase 2: 1

Top Sponsors

  • Mayo Clinic2
  • Cook Children's Health Care System1

Indications

  • Cancer3
  • Insulinoma1
  • Congenital Hyperinsulinism1
  • Malignant Brain Neoplasm1
  • Glioma1

Rochester, Minnesota2 trials

An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors

Mayo Clinic in Rochester

Phase 2
Sequential Treatments or Combinations Including Dasatinib, Quercetin, Fisetin and/or Temozolomide for the Treatment of Previously Treated Glioma With Residual Disease

Mayo Clinic in Rochester

Early 1

Fort Worth, Texas1 trial

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Cook Children's Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.